Adverum Biotechnologies, Inc.

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11 12
Rok finansowy 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 1 2 1 2 2 0 0 8 0 4 1
Przychód Δ r/r 0.0% 1500.0% 19.2% 305.4% -37.3% 27.1% -12.8% -84.5% -100.0% inf% -100.0% inf% -72.2%
Marża brutto 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% -inf% 38.1% -inf% -56.8% 100.0%
EBIT (mln) -2 -3 -24 -48 -115 -59 -78 -69 -118 -146 -157 -124 -139
EBIT Δ r/r 0.0% 90.2% 606.5% 96.0% 141.1% -49.0% 32.7% -12.2% 72.1% 23.9% 7.5% -21.2% 12.4%
EBIT (%) -6053.3% -719.6% -4266.1% -2062.2% -7923.3% -3182.6% -4843.7% -27418.0% 0.0% -1948.3% 0.0% -3438.6% -13915.9%
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 0 -3 0 0
EBITDA (mln) -2 -4 -24 -43 6 -57 -66 -67 -114 -141 -151 -118 -136
EBITDA(%) -6070.0% -734.2% -4266.1% -1840.3% 422.3% -3069.3% -4114.8% -26788.8% 0.0% -1886.4% 0.0% -3281.9% -13550.6%
Podatek (mln) 0 -0 -0 2 -1 0 -1 0 1 0 0 -1 0
Zysk Netto (mln) -2 -5 -25 -47 -114 -56 -73 -64 -118 -146 -155 -117 -131
Zysk netto Δ r/r 0.0% 191.3% 381.5% 86.8% 139.7% -50.6% 29.4% -11.2% 82.2% 23.9% 6.2% -24.2% 11.7%
Zysk netto (%) -6036.7% -1099.2% -4441.3% -2046.3% -7817.7% -3036.6% -4505.4% -25794.4% 0.0% -1940.5% 0.0% -3254.6% -13092.7%
EPS -0.0872 -0.25 -1.12 -1.84 -3.14 -1.29 -1.18 -10.06 -13.8 -14.85 -15.57 -11.62 -6.62
EPS (rozwodnione) -0.0872 -0.25 -1.12 -1.84 -3.14 -1.29 -1.18 -10.06 -13.8 -14.85 -15.57 -11.62 -6.62
Ilośc akcji (mln) 21 21 23 25 36 44 61 6 9 10 10 10 20
Ważona ilośc akcji (mln) 21 21 23 26 36 44 61 6 9 10 10 10 20
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD